Parnassus Investments
NVO

Parnassus Investments’s Novo Nordisk NVO Stock Holding History

Parnassus Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-969,015
Closed -$49.3M – 143
2025
Q4 		$49.3M Sell
969,015
-44,669
-4% -$2.28M 0.13% 89
2025
Q3 		$56.2M Buy
1,013,684
+2,138
+0.2% +$125K 0.13% 90
2025
Q2 		$69.8M Buy
1,011,546
+85,463
+9% +$5.81M 0.16% 78
2025
Q1 		$64.3M Buy
926,083
+332,361
+56% +$27.5M 0.15% 88
2024
Q4 		$51.1M Buy
+593,722
New +$64.2M 0.11% 96
2014
Q3 		– Sell
-176,000
Closed -$4.07M – 114
2014
Q2 		$4.07M Hold
176,000
– – 0.04% 104
2014
Q1 		$4.02M Sell
176,000
-44,000
-20% -$937K 0.04% 104
2013
Q4 		$4.07M Buy
220,000
+70,000
+47% +$1.22M 0.04% 107
2013
Q3 		$2.54M Buy
+150,000
New +$2.52M 0.03% 109

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Parnassus Investments's NVO Position: Q1 2026 in Review

Parnassus Investments sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 969,015 shares — an estimated $49.3M sold.

Parnassus Investments first reported a position in NVO in Q3 2013 and held it in 9 quarters. The position peaked at $69.8M in Q2 2025. 1,278 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Parnassus Investments reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Parnassus Investments sold 969,015 Novo Nordisk shares in Q1 2026, an estimated $49.3M.
  • Parnassus Investments first reported a position in Novo Nordisk in Q3 2013 and held it in 9 quarters.
  • Parnassus Investments's Novo Nordisk position peaked at $69.8M in Q2 2025.
  • 1,278 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Parnassus Investments's 13F filing for Q1 2026, filed 12 May 2026.